scispace - formally typeset
A

Antonino Carbone

Researcher at University of Bari

Publications -  517
Citations -  20723

Antonino Carbone is an academic researcher from University of Bari. The author has contributed to research in topics: Lymphoma & Medicine. The author has an hindex of 77, co-authored 474 publications receiving 19748 citations. Previous affiliations of Antonino Carbone include University of Turin & University of Texas MD Anderson Cancer Center.

Papers
More filters
Journal ArticleDOI

ALK+ Lymphoma: Clinico-Pathological Findings and Outcome

TL;DR: Multivariate analysis identified ALK expression and the International Prognostic Index as independent variables that were able to predict survival among T/null primary, systemic anaplastic large-cell lymphoma.
Journal ArticleDOI

A multicenter study of treatment of primary CNS lymphoma

TL;DR: Age, performance status, lactate dehydrogenase serum level, CSF protein level, site of disease, and use of HD-MTX were all predictors of survival, and combined CHT-RT is superior to RT alone.
Journal ArticleDOI

HIV-associated lymphomas and gamma-herpesviruses

TL;DR: The current knowledge about HIV-associated lymphomas can be summarized in the following key points: lymphomas specifically occurring in patients with HIV infection are closely linked to other viral diseases; AIDS lymphomas fall in a spectrum of B-cell differentiation where those associated with EBV or KSHV commonly exhibit plasmablastic differentiation.
Journal ArticleDOI

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial.

Viviana Galimberti, +201 more
- 01 Oct 2018 - 
TL;DR: The findings of the IBCSG 23-01 trial corroborate those obtained at 5 years and are consistent with those of the 10-year follow-up analysis of the Z0011 trial, and support the current practice of not doing an axillary dissection when the tumour burden in the sentinel nodes is minimal or moderate.